Dear Colleagues, Friends, investors and Supporters, Financial uncertainty is no longer an abstract risk. Across every investor category, the concern is the same. A major financial shock can erase years of retirement progress. That reality is driving growing interest in durable, healthcare based hard assets, especially those tied to needs that do not disappear in a recession.  One of the most durable needs in healthcare is spine care. Back pain is not going away, and even during economic downturns, patients still require treatment, often escalating to surgery when function is lost. What is changing is how spine care should be delivered. Traditional fusion can be effective, but it is also a destructive reconstruction that frequently contributes to adjacent level breakdown and revision surgery. The market is pivoting toward motion preserving, outpatient solutions, and we are leading that change. You might be wondering, why am I writing to you? Many investors, physicians and non physicians alike, are asking whether diversifying retirement assets into healthcare hard assets is a practical hedge against financial shock. KIC Ventures was built for exactly this moment. It is a physician founded platform advancing a fundamental human need with long term demand and a clear pathway to scale. KIC Ventures is a physician founded private equity healthtech firm founded by Harvard trained professor and orthopedic spine surgeon Dr. Kingsley R. Chin. We are advancing Less Exposure Spine Surgery (LESS™) and the REP™ philosophy, Restore Function, Early Treatment, Preserve Anatomy, to help shift spine care from rigid fusion toward motion preserving outpatient procedures. We have raised over 30 million dollars, with a significant percentage invested by physicians, because they understand both the clinical inevitability of spine disease and the resilience of spine technology as a hard asset category. Our credibility is rooted in both leadership and longevity. We are physician led by Harvard trained spine surgeons, CEO and CMO, supported by leadership with Wharton, Harvard Business School, and JP Morgan healthcare investing experience. Our team has worked together for over 17 years. We also have a proven innovation track record, including the sale of the MANTIS percutaneous spinal system to Stryker, a company founded by Dr. Homer Stryker, an orthopedic surgeon and inventor. This creates a direct connection between our surgeon led foundation and one of the most successful surgeon founded orthopedic technology companies in the world. Surgeon founded platforms have proven their ability to scale into enduring healthcare leaders. Kaiser Permanente has over 100 billion dollars in annual operating revenue and Stryker has over 20 billion dollars in annual net sales. These results demonstrate what long term physician led innovation can become. We have built a portfolio of hard medical assets by controlling our own development and production through the acquisition of AxioMed and its manufacturing facilities, alongside NanoFuse Biologics. While many of the major spine companies have stayed on the sidelines of the interventional market, our NANISX platform has already trained over 500 physicians in this Interventional Spine Surgery niche, creating a meaningful head start. An investment in KIC Ventures is fundamentally de risked by over 15 years of clinical proof. Over 90 million dollars has been invested into the AxioMed viscoelastic disc, the first and only of its kind to complete a United States IDE trial, demonstrating over 10 years of human clinical data with zero device failures. Our leadership team has worked together for over 17 years, investing over 100 million dollars in direct capital and reinvested revenue, including the successful sale of MANTIS to Stryker. We opened a 15 million dollar Series A to accelerate global scale and have already closed the first 5 million dollars. Our vision is bigger than a single product. We believe spine care will be transformed through vertical integration, similar to how Kaiser Permanente was founded by a surgeon, Dr. Sidney Garfield, to redesign care delivery around aligned incentives and scalable systems. We are building that same kind of long term platform for spine. This includes MedTech, LESS™ technologies, TechMed, MediConnects and the AxioMedX Smart Disc, Services, the LESS Institute and clinics, and Community, the LESS Society. This platform is designed to empower physicians and standardize adoption. I have enclosed our Investor Edge brochure for your review. Many investors are choosing to open a self directed IRA to diversify a portion of their retirement into healthcare hard assets and pursue tax advantaged growth. If you would like to learn how you can invest in KIC Ventures through your IRA or 401(k), I would be happy to schedule a brief call or connect you with a current investor for a peer to peer discussion. With appreciation, The Executive Council | KIC Ventures Call Aditya Humad (267-342-3968) or visit www.KICVentures.com.